Drugs / Darcilide
last change Dec 2025 re-read 2 minutes ago

Darcilide

Developed for
breast neoplasm
Investigated by
Second Affiliated Hospital of Soochow University

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT06235931 Feb 2024 → Dec 2025 overdue breast neoplasm Second Affiliated Hospital of Soochow University Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Darcilide ClinicalTrials.gov intervention name — accepted as the source's own label NCT06235931